Tao Luo

机构：Guangxi Medical University, Sichuan University, Tumor Hospital of Guangxi Medical University · ORCID：0000-0001-7597-8108

发表论文 12 篇 · 总被引 52 次 · h-index 4

代表论文

• LBA19 Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer (PHILA): A randomized phase III trial (2022 · Annals of Oncology · 被引 18)
• Ultrahigh Molecular Weight Polyethylene Lamellar‐Thin Framework on Square Meter Scale (Adv. Mater. 46/2022) (2022 · Advanced Materials · 被引 14)
• The Effects of Open Innovation Based on Mergers and Acquisitions on Innovative Behavior of Enterprises: Evidence From Chinese Listed Enterprises (2022 · Frontiers in Psychology · 被引 7)
• The Effect of Health Education on Migration Health: Evidence from a Large Migrant Survey in China (2023 · Health & Social Care in the Community · 被引 4)
• Simultaneous curative resection may improve the long-term survival of patients diagnosed with colorectal liver metastases: A propensity score–matching study (2025 · Surgery · 被引 3)
• The Effect of Workplace Violence on the Health of Healthcare Workers: Empirical Evidence From a Multicenter Cross-Sectional Study in China (2025 · International Journal of Public Health · 被引 2)